rs61754796

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_002485.5(NBN):​c.628G>T​(p.Val210Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000756 in 1,613,198 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V210L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00049 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00078 ( 1 hom. )

Consequence

NBN
NM_002485.5 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:11B:10O:2

Conservation

PhyloP100: -0.408

Publications

25 publications found
Variant links:
Genes affected
NBN (HGNC:7652): (nibrin) Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation. [provided by RefSeq, Jul 2008]
NBN Gene-Disease associations (from GenCC):
  • Nijmegen breakage syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Orphanet, ClinGen
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • idiopathic aplastic anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.034131557).
BP6
Variant 8-89971247-C-A is Benign according to our data. Variant chr8-89971247-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 127014.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.000784 (1145/1460924) while in subpopulation NFE AF = 0.000942 (1047/1111454). AF 95% confidence interval is 0.000894. There are 1 homozygotes in GnomAdExome4. There are 552 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002485.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBN
NM_002485.5
MANE Select
c.628G>Tp.Val210Phe
missense
Exon 6 of 16NP_002476.2
NBN
NM_001024688.3
c.382G>Tp.Val128Phe
missense
Exon 7 of 17NP_001019859.1A0A0C4DG07
NBN
NM_001440379.1
c.382G>Tp.Val128Phe
missense
Exon 6 of 16NP_001427308.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBN
ENST00000265433.8
TSL:1 MANE Select
c.628G>Tp.Val210Phe
missense
Exon 6 of 16ENSP00000265433.4O60934
NBN
ENST00000697309.1
c.628G>Tp.Val210Phe
missense
Exon 6 of 15ENSP00000513244.1A0A8V8TKY5
NBN
ENST00000697293.1
c.628G>Tp.Val210Phe
missense
Exon 6 of 17ENSP00000513230.1A0A8V8TM80

Frequencies

GnomAD3 genomes
AF:
0.000480
AC:
73
AN:
152156
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000926
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000403
AC:
101
AN:
250916
AF XY:
0.000398
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000925
Gnomad NFE exome
AF:
0.000767
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000784
AC:
1145
AN:
1460924
Hom.:
1
Cov.:
30
AF XY:
0.000759
AC XY:
552
AN XY:
726798
show subpopulations
African (AFR)
AF:
0.0000898
AC:
3
AN:
33424
American (AMR)
AF:
0.000179
AC:
8
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26106
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39596
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86244
European-Finnish (FIN)
AF:
0.000188
AC:
10
AN:
53330
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5744
European-Non Finnish (NFE)
AF:
0.000942
AC:
1047
AN:
1111454
Other (OTH)
AF:
0.00109
AC:
66
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
56
111
167
222
278
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000486
AC:
74
AN:
152274
Hom.:
0
Cov.:
33
AF XY:
0.000430
AC XY:
32
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41562
American (AMR)
AF:
0.0000653
AC:
1
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000941
AC:
64
AN:
68006
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000696
Hom.:
1
Bravo
AF:
0.000552
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.000486
AC:
59
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00115
EpiControl
AF:
0.00101

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
4
not provided (8)
-
3
2
Microcephaly, normal intelligence and immunodeficiency (5)
-
2
1
not specified (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
1
-
Aplastic anemia;C0023449:Acute lymphoid leukemia;C0398791:Microcephaly, normal intelligence and immunodeficiency (1)
-
-
1
Hereditary cancer (1)
-
1
-
Malignant tumor of breast (1)
-
1
-
NBN-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.11
CADD
Benign
16
DANN
Uncertain
0.98
DEOGEN2
Benign
0.18
T
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.037
N
LIST_S2
Uncertain
0.88
D
M_CAP
Benign
0.077
D
MetaRNN
Benign
0.034
T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
1.4
L
PhyloP100
-0.41
PrimateAI
Benign
0.28
T
PROVEAN
Uncertain
-2.4
N
REVEL
Benign
0.28
Sift
Uncertain
0.0060
D
Sift4G
Uncertain
0.020
D
Polyphen
0.21
B
Vest4
0.58
MVP
0.80
MPC
0.094
ClinPred
0.041
T
GERP RS
-1.9
Varity_R
0.12
gMVP
0.66
Mutation Taster
=27/73
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61754796; hg19: chr8-90983475; API